NEW YORK, July 31- Genomic Solutions announced on Tuesday a drop in sales and a plateau in revenues during the second quarter. 

Second quarter revenues were $4.5 million, essentially the same as the comparable quarter last year. Although revenues for this latest quarter are much lower than what was projected at the end of the first quarter, the company began warning shareholders almost one month ago that decreased sales would likely flatten revenues during the second quarter. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.